# A Study to Evaluate Topical Phenylephrine Gel in the Management of Faecal Incontinence

> **NCT00420797** · PHASE3 · WITHDRAWN · sponsor: **S.L.A. Pharma AG**

## Conditions studied

- Faecal Incontinence

## Interventions

- **DRUG:** 10% Phenylephrine hydrochloride gel

## Key facts

- **NCT ID:** NCT00420797
- **Lead sponsor:** S.L.A. Pharma AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-02
- **Primary completion:** —
- **Final completion:** 2007-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Terminated, new protocol to be developed
- **Last updated:** 2015-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00420797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00420797, "A Study to Evaluate Topical Phenylephrine Gel in the Management of Faecal Incontinence". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00420797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*